These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6605987)

  • 21. Genetic control of immune response to myoglobin. Ir gene function in genetic restriction between T and B lymphocytes.
    Kohno Y; Berzofsky JA
    J Exp Med; 1982 Nov; 156(5):1486-501. PubMed ID: 6813419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection for amino acid sequence and J beta element usage in the beta chain of DBA/2V beta b- and DBA/2V beta a-derived myoglobin-specific T cell clones.
    Ruberti G; Paragas V; Kim D; Fathman CG
    J Immunol; 1993 Dec; 151(11):6185-94. PubMed ID: 8245460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of a distinctive differentiating antigen of activated mouse T- and B-lymphocytes--AKA-1].
    Nesterenko VG; Novikova TK; Fontalin LN; Vekhnik E; Rubakova EI
    Biull Eksp Biol Med; 1980 Oct; 90(10):449-51. PubMed ID: 6968597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells.
    Glimcher LH; Kim KJ; Green I; Paul WE
    J Exp Med; 1982 Feb; 155(2):445-59. PubMed ID: 6460073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural study of internalization and recycling of antigen by antigen presenting cells.
    Lin J; Berzofsky JA; Delovitch TL
    J Mol Cell Immunol; 1988; 3(6):321-45. PubMed ID: 3075924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.
    Jones KW; Hackett CJ
    Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
    Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
    J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the responding populations for the generation of proliferative response to syngeneic Meth A tumor in BALB/c mice: requirement of T and B cell collaboration.
    Ting CC; Rodrigues D; Hong JX
    J Immunol; 1980 Dec; 125(6):2742-8. PubMed ID: 6968794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.
    Kleijmeer MJ; Ossevoort MA; van Veen CJ; van Hellemond JJ; Neefjes JJ; Kast WM; Melief CJ; Geuze HJ
    J Immunol; 1995 Jun; 154(11):5715-24. PubMed ID: 7751623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
    Brozek C; Umetsu D; Schneeberger E; Geha RS
    J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
    Gombos I; Detre C; Vámosi G; Matkó J
    Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.